45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          IMPORTANCE

          Laws and attitudes toward marijuana in the United States are becoming more permissive but little is known about whether the prevalence rates of marijuana use and marijuana use disorders have changed in the 21st century.

          OBJECTIVE

          To present nationally representative information on the past-year prevalence rates of marijuana use, marijuana use disorder, and marijuana use disorder among marijuana users in the US adult general population and whether this has changed between 2001–2002 and 2012–2013.

          DESIGN, SETTING, AND PARTICIPANTS

          Face-to-face interviews conducted in surveys of 2 nationally representative samples of US adults: the National Epidemiologic Survey on Alcohol and Related Conditions (data collected April 2001-April 2002; N = 43 093) and the National Epidemiologic Survey on Alcohol and Related Conditions–III (data collected April 2012-June 2013; N = 36 309). Data were analyzed March through May 2015.

          MAIN OUTCOMES AND MEASURES

          Past-year marijuana use and DSM-IV marijuana use disorder (abuse or dependence).

          RESULTS

          The past-year prevalence of marijuana use was 4.1% (SE, 0.15) in 2001–2002 and 9.5% (SE, 0.27) in 2012–2013, a significant increase ( P < .05). Significant increases were also found across demographic subgroups (sex, age, race/ethnicity, education, marital status, income, urban/rural, and region). The past-year prevalence of DSM-IV marijuana use disorder was 1.5% (0.08) in 2001–2002 and 2.9% (SE, 0.13) in 2012–2013 ( P < .05). With few exceptions, increases in the prevalence of marijuana use disorder between 2001–2002 and 2012–2013 were also statistically significant ( P < .05) across demographic subgroups. However, the prevalence of marijuana use disorder among marijuana users decreased significantly from 2001–2002 (35.6%; SE, 1.37) to 2012–2013 (30.6%; SE, 1.04).

          CONCLUSIONS AND RELEVANCE

          The prevalence of marijuana use more than doubled between 2001–2002 and 2012–2013, and there was a large increase in marijuana use disorders during that time. While not all marijuana users experience problems, nearly 3 of 10 marijuana users manifested a marijuana use disorder in 2012–2013. Because the risk for marijuana use disorder did not increase among users, the increase in prevalence of marijuana use disorder is owing to an increase in prevalence of users in the US adult population. Given changing laws and attitudes toward marijuana, a balanced presentation of the likelihood of adverse consequences of marijuana use to policy makers, professionals, and the public is needed.

          Related collections

          Author and article information

          Journal
          101589550
          40869
          JAMA Psychiatry
          JAMA Psychiatry
          JAMA psychiatry
          2168-622X
          2168-6238
          22 September 2016
          December 2015
          01 December 2016
          : 72
          : 12
          : 1235-1242
          Affiliations
          Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York (Hasin); Mailman School of Public Health, Columbia University, New York, New York (Hasin); New York State Psychiatric Institute, New York (Hasin); Laboratory of Epidemiology and Biometry, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland (Saha, Goldstein, Chou, Zhang, Jung, Pickering, Ruan, Smith, Huang, Grant); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York (Kerridge)
          Author notes
          Corresponding Author: Bridget F. Grant, PhD, PhD, Laboratory of Epidemiology and Biometry, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Ln, Room 3077, Rockville, MD 20852 ( bgrant@ 123456mail.nih.gov )
          Article
          PMC5037576 PMC5037576 5037576 nihpa818093
          10.1001/jamapsychiatry.2015.1858
          5037576
          26502112
          ab9a8808-e3ad-4b3f-a3e2-3c1d6b869767
          History
          Categories
          Article

          Comments

          Comment on this article